Overexpression of kidney phosphatidylinositol 4-kinaseβ and phospholipase C γ1 proteins in two rodent models of polycystic kidney disease

• Published in: Biochimica et biophysica acta. Molecular basis of disease 2002-05, Vol.1587 (1), p.99-106
• Main Authors: Cuozzo, F.P., Mishra, S., Jiang, J., Aukema, H.M.
• Format: Article
• Language: English
• Subjects: Animal model; Immunoblotting; Phosphatidylinositol 4-kinaseβ; Phosphoinositide metabolism; Phospholipase C γ1; Polycystic kidney disease
• ISSN: 0925-4439; 1879-260X
• DOI: 10.1016/S0925-4439(02)00072-8

Our studies of renal phosphoinositide levels and metabolism in the pcy mouse with polycystic kidney disease (PKD) suggest that phosphatidylinositol kinase (PtdInsK) and phospholipase C (PLC) are elevated in this renal disorder. Therefore, the steady-state levels of select isoforms of these enzymes were examined in renal cytosolic and particulate (detergent-soluble) fractions in male and female normal and CD1- pcy/ pcy ( pcy) mice at 60, 120 and 180 days of age, and in male and female normal and diseased (Han:SPRD- cy) rats at 28 and 70 days of age. Disease-related increases in phosphatidylinositol 4-kinaseβ (PtdIns4Kβ) and PLC γ1 levels were present in both models. PtdIns4Kβ levels were higher by as much as 233% in pcy mice and by 95% in diseased Han:SPRD- cy rats compared to normals of the same age and gender. Steady-state levels of PLC γ1 were as much as 74% and 35% higher in pcy mice and diseased Han:SPRD- cy rats, respectively, compared to their controls. The consistency of these alterations in two accepted models of PKD indicates the importance of the phosphoinositide signalling pathway in the evolution of this disorder, and represents a potential site for therapeutic intervention.